Skip to main content
    B

    Bausch Health Companies Inc (BHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $8.43
    +0.07 (+0.90%)

    Market Cap: $3.13B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Bausch Health Companies Inc (BHC) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Bausch Health Companies (BHC) trades at 1.7x trailing earnings and 0.3x sales. Its P/E of 1.7x is below its 5-year median of 2.0x. Its forward P/E is 1.9x. The median P/E across 10 similar companies is 11.7x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 10.5% lower over the next year. Its free cash flow yield is 59.0%.

    MultipleValue
    P/E (trailing)1.7x
    Forward P/E1.9x
    Price to sales0.3x
    EV/EBITDA8.7x
    Price to FCF1.7x
    EV/FCF11.4x
    PEGN/A
    FCF yield59.0%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 41.4% below 2.9x and its P/S is 40.0% below 0.5x.

    MultipleCurrent5-year median10-year median
    P/E1.7x2.0x2.9x
    P/S0.3x0.3x0.5x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 1.8x in 2025 to 6.7x in 2019. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$6.951.8x0.3xN/A
    2024$8.062.1x0.3xN/A
    2023$8.022.3x0.3xN/A
    2022$6.282.1x0.3xN/A
    2021$27.616.2x1.2xN/A
    2020$20.805.2x107.2x14.0x
    2019$29.926.7x1.2x10.1x
    2018$18.474.6x0.8x2.4x
    2017$20.785.4x0.8x1.3x
    2016$14.522.6x0.5x1.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BHC

    What is BHC's forward P/E ratio?

    Bausch Health Companies has a forward P/E ratio of 1.9x.

    Is BHC stock overvalued?

    GNG's valuation label for BHC is Undervalued. Its P/E of 1.7x compares with a median of 11.7x across 10 similar companies.

    What is BHC's price to sales ratio?

    Bausch Health Companies has a price to sales ratio of 0.3x.

    What is Bausch Health Companies's average P/E ratio over 5 years?

    Bausch Health Companies's median P/E over the last 5 years is 2.0x, from 60 month-end values through Oct 2026.